Comparative susceptibility of Gemella morbillorum to 13 antimicrobial agents. (June 2022)

• Record Type: Journal Article
• Authors: Goldstein, Ellie JC.; Merriam, C. Vreni; Claros, Marina C.; Citron, Diane M.
• Is Part Of: Anaerobe. Volume 75(2022)
• Publication Date: 2022-06
• Subjects: Gemella morbillorum -- Metronidazole resistance -- Endocarditis; Anaerobic infections -- Periodicals; Anaerobic bacteria -- Periodicals; Bacterial diseases -- Periodicals; Computer network resources; Anaerobic protozoa -- Periodicals; 579.3
• DOI: 10.1016/j.anaerobe.2022.102573
• Languages: English
• ISSNs: 1075-9964

Abstract

Abstract: The in vitro activity of 13 antimicrobials against clinical isolates of Gemella morbillorum showed good susceptibility to clindamycin, all beta-lactams agents studied except cefoxitin (MIC90, 4 μg/ml) and fluoroquinolones. There was 36% metronidazole resistance. Highlights: Gemella morbillorum is a difficult organism to identify G. morbillorum causes serious infections such as endocarditis but here is limited data High Metronidazole MICs (>32 μ g / m l ) was seen in 4/11 (36%) isolates.